Jens Ricke

Jens Ricke

Auto-generated profile, based on publicly available information

Jens Ricke

Department of Radiology, Charité Virchow-Klinikum, Medical Faculty, Humboldt University, Augustenburgerplatz 1, 13353 Berlin, Germany

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2003 in European Radiology
Verified
Journal Article
Closed access
JRJens Ricke
Jens Ricke
JSJalid Sehouli
Jalid Sehouli
CHConstanze Hach
Constanze Hach
EHEnrique Hänninen
Enrique Hänninen
WLWerner Lichtenegger
Werner Lichtenegger
RFRoland Felix
Roland Felix

1 January 2001 in European Journal of Radiology
Verified
Journal Article
Closed access
JRJ. Ricke
J. Ricke
KKK.-J. Klose
K.-J. Klose
MMM. Mignon
M. Mignon
KÖK. Öberg
K. Öberg
BWB. Wiedenmann
B. Wiedenmann

1 May 2000 in European Journal of Cancer
Verified
Journal Article
Closed access
JRJ Ricke
J Ricke
HBH Bartelink
H Bartelink

1 July 2000 in Digestion
Verified
Journal Article
Closed access
PDF file
JRJ. Ricke
J. Ricke
KKK.-J. Klose
K.-J. Klose
Purpose: To give recommendations for diagnostic imaging workflow in suspected neuroendocrine tumours. Materials and Methods: Recommendations for imaging workflow were elaborated by consensus of researchers in neuroendocrine tumours. Results: Workflow charts are presented for: (1) nonfunctional and functional endocrine tumours of the pancreas (except insulinoma); (2) insulinoma; (3) ECL cell tumour; (4) assessment of unknown primaries in functional and nonfunctional neuroendocrine tumours of the gut; (5) assessment of metastases in functional and nonfunctional neuroendocrine tumours of the gut. Conclusions: The workflow charts facilitate diagnosis of neuroendocrine tumours as well as the design of controlled studies.

1 April 2000 in Investigative Radiology
Verified
Journal Article
Closed access
JRJens Ricke
Jens Ricke
EHEnrique Lopez Hänninen
Enrique Lopez Hänninen
HAHolger Amthauer
Holger Amthauer
ALArne Lemke
Arne Lemke
RFRoland Felix
Roland Felix
Ricke J, Lopez Hänninen E, Amthauer H, Lemke A, Felix R. Assessment of the vascularization of neuroendocrine tumors by stimulated acoustic emission of SH U 508A ultrasound contrast agent and color or power Doppler sonography. Invest Radiol 2000;35:253–259. To assess the vascularization of neuroendocrine tumors by stimulated acoustic emission (SAE) of SH U 508A during the blood pool phase in comparison with contrast-enhanced Doppler sonography. Thirty-six patients with neuroendocrine tumors received contrast-enhanced Doppler sonography and 21, an additional SAE. To classify tumor perfusion on Doppler sonography, a 4-step rating score was introduced: (1) no vessels (hypoperfusion); (2) one feeding or central vessel (hypoperfusion); (3) some vessels (hyperperfusion); and (4) disseminated vessels (hyperperfusion). In 36 patients, 1 pancreatic primary tumor, 33 liver metastases, 1 splenic metastasis, and 1 lymph node metastasis were examined. Results were correlated with biphasic spiral CT (n = 35) and angiography (n = 2). Arterial-phase CT and digital subtraction angiography revealed 18 hyper- and 18 hypoperfused lesions. Contrast-enhanced Doppler correctly classified 15 of 18 patients (83%) with hyperperfused lesions as well as 16 of 18 (89%) hypoperfused tumors by applying the rating score. SAE correctly identified 4 of 9 hyperperfused lesions (44%), 2 were isoperfused compared with normal liver tissue (22%), and 3 were hypoperfused (33%). Of 12 hypoperfused lesions, 11 were classified correctly (92%), and 1 showed isoperfusion. Hence, the positive and negative predictive values for SAE were 80% and 69%, respectively. For contrast-enhanced Doppler sonography, positive and negative predictive values were 88% and 84%, respectively. Blood pool SAE failed to determine subtle tumor perfusion correctly. The rating score for contrast-enhanced Doppler sonography characterized tumor perfusion with high accuracy. The use of a contrast agent significantly improved perfusion characterization.

21 February 2000 in Computerized Medical Imaging and Graphics
Verified
Journal Article
Closed access
JRJ Ricke
J Ricke
EHE.L Hänninen
E.L Hänninen
CZC Zielinski
C Zielinski
HAH Amthauer
H Amthauer
CSC Stroszczynski
C Stroszczynski
NHN Hosten
N Hosten